Y-Intercept (HK)’s Edwards Lifesciences EW Stock Holding History

Y-Intercept (HK)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.26M	Buy	+36,042	New	+$3.02M	0.06%	448
2026 Q1	–	Sell	-9,550	Closed	-$814K	–	1696
2025 Q4	$814K	Buy	+9,550	New	+$784K	0.02%	1073
2025 Q3	–	Sell	-168,378	Closed	-$13.2M	–	1700
2025 Q2	$13.2M	Buy	168,378 +141,843	+535%	+$10.6M	0.32%	38
2025 Q1	$1.92M	Sell	26,535 -11,686	-31%	-$836K	0.13%	197
2024 Q4	$2.83M	Buy	38,221 +24,398	+177%	+$1.71M	0.19%	138
2024 Q3	$912K	Sell	13,823 -3,122	-18%	-$227K	0.06%	487
2024 Q2	$1.57M	Buy	+16,945	New	+$1.5M	0.09%	325
2024 Q1	–	Sell	-13,034	Closed	-$994K	–	1480
2023 Q4	$994K	Sell	13,034 -48,441	-79%	-$3.37M	0.09%	320
2023 Q3	$4.26M	Buy	61,475 +44,860	+270%	+$3.6M	0.42%	27
2023 Q2	$1.57M	Buy	16,615 +7,893	+90%	+$686K	0.17%	155
2023 Q1	$722K	Sell	8,722 -10,324	-54%	-$812K	0.08%	369
2022 Q4	$1.42M	Sell	19,046 -22,190	-54%	-$1.71M	0.21%	113
2022 Q3	$3.41M	Buy	+41,236	New	+$3.97M	0.34%	50
2021 Q4	–	Sell	-22,795	Closed	-$2.58M	–	659
2021 Q3	$2.58M	Buy	+22,795	New	+$2.6M	0.47%	28

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Y-Intercept (HK)'s EW Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Edwards Lifesciences (EW) in Q2 2026: 36,042 shares worth $3.26M. The stake represents 0.06% of the portfolio and ranks #448 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in EW as recently as Q4 2025.

Y-Intercept (HK) first reported a position in EW in Q3 2021 and has held it in 14 quarters since. The position peaked at $13.2M in Q2 2025. 287 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Y-Intercept (HK) held 36,042 shares of Edwards Lifesciences worth $3.26M as of Q2 2026.
Edwards Lifesciences was a new Y-Intercept (HK) position in Q2 2026.
Edwards Lifesciences made up 0.06% of Y-Intercept (HK)'s portfolio in Q2 2026, its #448 holding.
Y-Intercept (HK) first reported a position in Edwards Lifesciences in Q3 2021 and has held it in 14 quarters since.
Y-Intercept (HK)'s Edwards Lifesciences position peaked at $13.2M in Q2 2025.
287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.